Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention

被引:50
|
作者
Ordovas, Jose M. [1 ]
机构
[1] Tufts Univ, Nutr & Genom Lab, USDA, Human Nutr Ctr Aging, 711 Washington St, Boston, MA 02111 USA
来源
AMERICAN JOURNAL OF CLINICAL NUTRITION | 2009年 / 89卷 / 05期
关键词
APOLIPOPROTEIN-E POLYMORPHISM; POSTPRANDIAL LIPOPROTEIN METABOLISM; PROMOTER -219G/T POLYMORPHISM; HEALTH OUTCOMES IMPLICATIONS; ACTIVATED-RECEPTOR-GAMMA; FAT DIETARY PATTERN; SERUM-LIPIDS; E PHENOTYPE; E GENOTYPE; PLASMA-LIPIDS;
D O I
10.3945/ajcn.2009.27113E
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Genetic polymorphism in human populations is part of the evolutionary process that results from the interaction between the environment and the human genome. Recent changes in diet have upset this equilibrium, potentially influencing the risk of most common morbidities such as cardiovascular diseases, obesity, diabetes, and cancer. Reduction of these conditions is a major public health concern, and such a reduction could be achieved by improving our ability to detect disease predisposition early in life and by providing more personalized behavioral recommendations for successful primary prevention. In terms of cardiovascular diseases, polymorphisms at multiple genes have been associated with differential effects in terms of lipid metabolism; however, the connection with cardiovascular disease has been more elusive, and considerable heterogeneity exists among studies regarding the predictive value of genetic markers. This may be because of experimental limitations, the intrinsic complexity of the phenotypes, and the aforementioned interactions with environmental factors. The integration of genetic and environmental complexity into current and future research will drive the field toward the implementation of clinical tools aimed at providing dietary advice optimized for the individual's genome. This may imply that dietary changes are implemented early in life to gain maximum benefit. However, it is important to highlight that most reported studies have focused on adult populations and to extrapolate these findings to children and adolescents may not be justified until proper studies have been carried out in these populations and until the ethical and legal issues associated with this new field are adequately addressed. Am J Clin Nutr 2009; 89(suppl): 1509S-17S.
引用
收藏
页码:S1509 / S1517
页数:9
相关论文
共 50 条
  • [41] Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease
    John W. Ostrominski
    Tiffany M. Powell-Wiley
    Current Atherosclerosis Reports, 2024, 26 : 11 - 23
  • [42] Optimal risk-assessment scheduling for primary prevention of cardiovascular disease
    Gasperoni, Francesca
    Jackson, Christopher H.
    Wood, Angela M.
    Sweeting, Michael J.
    Newcombe, Paul J.
    Stevens, David
    Barrett, Jessica K.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2024,
  • [43] Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease
    Dyakova, Mariana
    Shantikumar, Saran
    Colquitt, Jill L.
    Drew, Christian
    Sime, Morag
    MacIver, Joanna
    Wright, Nicola
    Clarke, Aileen
    Rees, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [44] Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease
    Ostrominski, John W.
    Powell-Wiley, Tiffany M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (01) : 11 - 23
  • [45] Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care
    Brotons, Carlos
    Moral, Irene
    Fernandez, Diana
    Puig, Mireia
    Calvo Bonacho, Eva
    Martinez Munoz, Paloma
    Catalina Romero, Carlos
    Quevedo Aguado, Luis Javier
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (07): : 562 - 568
  • [46] Epidemiology of cardiovascular risk factors in physically active elderly persons: study of lipids in primary prevention
    Mari Solivellas, B.
    Cabanes Martin, T.
    MEDICINA BALEAR, 2005, 20 (03): : 24 - 27
  • [47] Childhood risk factors for adult cardiovascular disease and primary prevention in childhood
    Celermajer, David S.
    Ayer, Julian G. J.
    HEART, 2006, 92 (11) : 1701 - 1706
  • [48] Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: Implications in cardiovascular risk factors management and primary prevention of cardiovascular disease
    Torres, Tiago
    Sales, Rita
    Vasconcelos, Carlos
    da Silva, Berta Martins
    Selores, Manuela
    JOURNAL OF DERMATOLOGY, 2013, 40 (11): : 923 - 926
  • [49] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [50] CLINICAL UTILITY OF LPA GENETIC CHARACTERIZATION FOR PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Trinder, M.
    Uddin, M. M.
    Finneran, P.
    Aragam, K.
    Natarajan, P.
    ATHEROSCLEROSIS, 2020, 315 : E15 - E16